Home » Newsletters » BioWorld Science

BioWorld Science

July 21, 2015

View Archived Issues

Aerosolized Ebola vaccine shows promising protective effect in nonhuman primates

Panther Biotechnology completes acquisition of Faulk Pharmaceuticals assets

Glypican-1 identified as potential diagnostic marker for pancreatic cancer

Heron Therapeutics resubmits Sustol NDA in U.S. for CINV

Cellceutix's brilacidin to advance to phase III for ABSSSI

Agenus acquires antibodies targeting CEACAM1

ASLAN and National Cancer Centre Singapore sign MOU to collaborate in gastric cancer

Fibrocell and Intrexon confirm IND filing of FCX-007 for recessive dystrophic epidermolysis bullosa

MGB Biopharma initiates phase I trial of MGB-BP-3 for C. difficile infections

Purdue Pharma patents morphinan analogs

Nanjing Sanhome Pharmaceutical discloses anti-HCV agents

Gilead introduces SYK inhibitors

Cadila divulges FFAR1 agonists

Bristol-Myers patents BRD4 inhibitors

BioMarin updates on development of talazoparib in breast cancer

Exelixis reports topline results from phase III trial of cabozantinib in renal cell carcinoma

DSMB recommends continuation of Graspa pancreatic cancer trial

Biotie starts phase III trial of tozadenant in Parkinson's disease

Nivolumab BMS approved in E.U. for squamous NSCLC

Novonco licenses rights to COH-29 from City of Hope

Purdue Pharma reports Nav1.7 channel blockers

Valeant agrees to acquire leading Egyptian pharmaceutical company

Virginia Commonwealth University patents NO-releasing allosteric Hb modifiers

SUVN-G3031 demonstrates procognitive effects without affecting sleep

TRV-101 reduces beta-amyloid and tau toxic aggregates in animal models of AD

CheckMate-025 study of Opdivo stopped early after meeting endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...